Showing 1621-1630 of 4938 results for "".
- Deepak Chadha is New Vice President of Regulatory Affairs for Suneva Medicalhttps://practicaldermatology.com/news/20140311-deepak_chadha_is_new_vicepresident_of_regulatory_affairs_for_suneva_medical/2459319/Suneva Medical appointed Deepak Chadha to Vice President of Regulatory Affairs. Chadha's role will be leading the development and implantation of regulatory practices. Chairman and Chief Executive Officer, Nicholas L. Teti, Jr. said, “Deepak has been responsible for several global regula
- EWG Releases 2012 Sunscreen Guide and Apphttps://practicaldermatology.com/news/20120608-ewg_releases_2012_sunscreen_guide_and_app/2459787/After rating 257 brands and more than 1,800 products, the Environmental Working Group (EWG) released its sixth annual Guide to Summer Sun. EWG recommends 1 in 4 of more than 800 beach and sport sunscreens, compared to 1 in 5 l
- Analysis Finds 'Substantial' Links Between Nail PsO Lesions and Locationshttps://practicaldermatology.com/news/Analysis-Finds-Substantial-Links-Between-Nail-PsO-Lesions-Locations/2471103/A spatial relationship between onycholysis and oil spots, with the intra-nail location of onycholysis being more distal compared to the nearest oil spots, was one of the primary observations in a new analysis of nail psoriasis published in Annals of Dermatology. “Analysis of the Intra-Nail
- Study: Atopic Asthma/Eczema Linked to Heightened Risk of Osteoarthritishttps://practicaldermatology.com/news/study-atopic-asthmaeczema-linked-to-heightened-risk-of-osteoarthritis/2461635/People with atopic diseases like asthma or eczema may be at heightened risk of osteoarthritis, according to research published online in the Annals of the Rheumatic Diseases. Drugs used to dampen d
- Hair Up Top: Restoration Names New CFOhttps://practicaldermatology.com/news/hair-up-top-restoration-names-new-cfo/2457955/Restoration Robotics, Inc. will have a new Chief Financial Officer next year. Industry veteran Mark L. Hair will fill the post effective January 5, 2018. Mr. Hair brings with him over 20 years of executive management, financial advisory, consulting, and public company exp
- Long-Term Ixekizumab Use Not Linked to Increased Cancer Risk: Analysishttps://practicaldermatology.com/news/long-term-ixekizumab-use-not-linked-to-increased-cancer-risk/2475704/Long-term treatment with ixekizumab (IXE) for psoriasis, psoriatic arthritis, and axial spondyloarthritis was not associated with increased risk of malignant neoplasms, according to a new analysis of pooled data from 25 randomized clinical trials.
- LEQSELVI™ Launches in U.S. as Oral Treatment for Severe Alopecia Areatahttps://practicaldermatology.com/news/leqselvitm-launches-in-us-as-oral-treatment-for-severe-alopecia-areata/2475680/Sun Pharmaceutical Industries Ltd. announced the U.S. commercial availability of LEQSELVI™ (deuruxolitinib), an oral Janus kinase (JAK) inhibitor indicated for the treatment of adults with severe alopecia areata, according to a press release from the manufacturer.
- LEO Pharma to Partner with Boehringer Ingelheim, Commercialize SPEVIGO® for GPPhttps://practicaldermatology.com/news/leo-pharma-to-partner-with-boehringer-ingelheim-commercialize-spevigo-for-gpp/2475663/LEO Pharma and Boehringer Ingelheim have entered into an exclusive global license and transfer agreement for the development and commercialization of the interleukin-36 (IL-36) receptor inhibitor SPEVIGO® (spesolimab), according to a news release.
- Anaysis: Linperlisib and Chidamide Safe, Effective in Advanced CTCLhttps://practicaldermatology.com/news/anaysis-linperlisib-and-chidamide-safe-effective-in-advanced-ctcl/2475518/An investigational combination of linperlisib and chidamide demonstrated clinical activity in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL), according to results from a phase 1 trial. The single-arm, n
- Study: 90% Would Purchase Red Light Therapy Deviceshttps://practicaldermatology.com/news/study-90-would-purchase-red-light-therapy-devices/2475498/New research published in the Journal of Clinical and Aesthetic Dermatology showed how social media is fueling the growing consumer demand for over-the-counter (OTC) red light therapy (RLT) devices. The authors of the